| Prev Close | 62.31 |
| Day Low/High | 61.18 / 62.74 |
| 52 Wk Low/High | 54.66 / 80.37 |
| Avg Volume | 2.84M |
| Exchange | NYSE |
| Shares Outstanding | 314.71M |
| Market Cap | 19.61B |
| EPS | 4.10 |
| P/E Ratio | 10.86 |
| Div & Yield | 1.85 (2.89%) |
A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.
While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.
You've spent the better half of a lifetime thinking about retiring. Don't let it all go to waste now.
McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.
Donation will help supply local first responders with crucial anti-overdose drug, help reduce overdose casualties in hard-hit communities
President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.
Former Executive Chairman Paul Jacobs is considering a leveraged buyout, which would be incredibly expensive and face tough regulatory scrutiny.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CAH, QEP, RGEN, THC, WD Downgrades: AUTO, FDUS, INTT, OLP, SIM, STRA, VALE Initiations: ORGS Read on to get TheStreet Quant Ratings' detailed report:
Company highlights its commitment during Patient Safety Awareness Week
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
National Association for Female Executives recognizes Cardinal Health for its dedication to drive female leaders forward
After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.
Could Amazon be lost in the jungle when it comes to the drug supply chain? RBC analysts say it's possible. Don't count on a big entrance for at least a few years.
Bitcoin, the bull market, and Amazon -- oh my! This is what you can't miss Wednesday.
The wholesale drug distributor says the way it operates its business would be difficult for another vendor to duplicate.
McKesson and Cardinal Health are alleged to have sent more than 12 million opioid doses to a single pharmacy in West Virginia over an eight-year period, according to a House committee probe.
In the last two weeks alone, three sectors have gotten hammered on announcements or reports about Amazon's plans.
As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?
The White House Council of Economic Advisers on Friday, Feb. 9, released a report on how the government can help bring down drug prices.
The free market is going to take back control of interest rates.
The stocks of healthcare giants such as United, Cigna and Anthem tumbled Tuesday following news that Amazon, Berkshire Hathaway and JPMorgan have banded together on a healthcare initiative for their workers.
Jim Cramer says watch out for those earnings reports this week, and use any pullback to put some money into a good index fund. You won't regret it.
